Compare AVTX & FLYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVTX | FLYE |
|---|---|---|
| Founded | 2011 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.9M | 8.5M |
| IPO Year | 2015 | 2024 |
| Metric | AVTX | FLYE |
|---|---|---|
| Price | $17.53 | $2.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $36.80 | N/A |
| AVG Volume (30 Days) | ★ 793.8K | 10.1K |
| Earning Date | 05-11-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.07 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $27,813,137.00 | $25,427,163.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2312.27 | N/A |
| 52 Week Low | $3.39 | $0.33 |
| 52 Week High | $20.72 | $21.80 |
| Indicator | AVTX | FLYE |
|---|---|---|
| Relative Strength Index (RSI) | 64.56 | 48.32 |
| Support Level | $17.18 | $1.74 |
| Resistance Level | $19.26 | $5.87 |
| Average True Range (ATR) | 1.19 | 0.16 |
| MACD | 0.27 | 0.14 |
| Stochastic Oscillator | 99.67 | 64.04 |
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
Fly-E Group Inc is an electric vehicle company that is principally engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters and related accessories under the brand Fly E-Bike. It also provides connectivity solutions and value-added services to their customers.